Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Feb 15, 2022, after the close
10-K filed Feb 28, 2022, 59 days after period end · 0001299130-22-000030
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $36.02M | $25.13M | $27.93M | $19.53M |
| Net Income | -$69.33M | $74.94M | -$91.00K |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$30.80M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
